Benefits
Cardiorespiratory endurance improvement
A 4-week human RCT of Oxyjun® (500 mg/day) demonstrated a significant 10-point increase in VO2 max scores in healthy adults compared to no change in placebo — a meaningful improvement in aerobic capacity attributable to improved cardiac output and oxygen utilization.
Cardiovascular protection and heart failure
Multiple clinical studies in heart failure patients show arjuna bark extract significantly improves ejection fraction, reduces angina frequency, and improves exercise tolerance. One study in stable angina patients showed arjuna was equivalent to isosorbide mononitrate for angina prevention over 3 months.
Blood pressure and arterial health
Arjuna extract reduces systolic and diastolic blood pressure through endothelial nitric oxide enhancement and direct smooth muscle relaxation. Clinical studies show 4–10 mmHg reductions in hypertensive patients with consistent supplementation.
Exercise-induced oxidative stress reduction
Arjuna's rich tannin and flavonoid content provides potent antioxidant protection against exercise-induced reactive oxygen species, reducing post-exercise lipid peroxidation, muscle damage markers, and recovery time.
Lipid profile improvement
Clinical studies show arjuna extract reduces total cholesterol, LDL, and triglycerides while improving HDL levels. The mechanisms include HMG-CoA reductase inhibition and increased hepatic LDL receptor expression.
Mechanism of action
Endothelial nitric oxide enhancement
Arjunolic acid and arjunic acid stimulate endothelial nitric oxide synthase (eNOS) activity and increase bioavailable nitric oxide — improving vascular tone, reducing blood pressure, and enhancing blood flow to working muscle tissue during exercise. This mechanism underlies both cardiovascular protection and performance enhancement.
Cardiac muscle calcium channel modulation
Arjuna glycosides modulate cardiac L-type calcium channels, improving cardiac contractility and stroke volume without the proarrhythmic risks associated with pharmaceutical calcium channel modulators. This inotropic effect explains improvements in ejection fraction in heart failure patients.
Free radical scavenging and antioxidant enzyme induction
Arjuna's dense tannin matrix (including arjunagenin and terminic acid) directly scavenges reactive oxygen species and induces endogenous antioxidant enzyme expression (SOD, catalase, GPx), providing both immediate and sustained antioxidant protection in cardiac and vascular tissue.
Clinical trials
Randomized, double-blind, placebo-controlled trial of Oxyjun® (500 mg/day) vs. placebo in 30 healthy adults for 4 weeks.
30 healthy adults. 4-week intervention.
Oxyjun® supplementation produced a significant 10-point increase in VO2 max score vs. no change in placebo. Significant improvements in cardiorespiratory fitness markers and exercise performance indices. Well-tolerated with no adverse effects. Citation caveat: original citation was supplier marketing page; specific PubMed citation needed.
Randomized crossover trial comparing arjuna bark extract (500 mg three times daily) vs. isosorbide mononitrate (40 mg/day) vs. placebo in 58 stable angina patients over 3 months.
58 stable angina patients. 3-month crossover design.
Arjuna extract significantly reduced angina frequency, improved exercise tolerance on treadmill test, and improved left ventricular ejection fraction. Efficacy comparable to isosorbide mononitrate with better tolerability profile.